Creutzfeldt Jakob Disease

Follow the links below to information on Creutzfeldt Jakob Disease (CJD) and variant CJD (vCJD) as well as other prion diseases such as Bovine Spongiform Encephalitis (BSE) and Transmissible Spongiform Encephalopathies (TSEs)

Reviewed August 2011

16 Resources Found

Results 1 to 16 displayed.

Title:   Creutzfeldt - Jakob Disease
Publisher:   Queensland Health
Description:   Creutzfeldt - Jakob disease (CJD) is a very rare disease that affects brain tissue in humans. When people first start to show symptoms, they usually present with confusion, disorientation and problems with walking. Death can occur up to two years after a person shows the first symptoms; however, most people die within six months. There is no treatment or cure.
Date:   Sep 2011
Title:   Growth hormone
Publisher:   Better Health Channel
Description:   Growth hormone is produced by the pituitary gland of the brain. Growth hormones determine height, bone length and muscle growth. Synthetic growth hormone will not help build muscle size and strength. Children who are experiencing stunted or slowed growth need their natural growth hormone levels checked by medical professionals before any drugs are administered.
Date:   Aug 2011
Title:   Notification and support for people exposed to the risk of Creutzfeldt-Jakob disease (CJD) (or other prion diseases) through medical treatment (iatrogenically)
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   CJD and variant CJD (vCJD) are rare and fatal diseases with very long incubation periods. While CJD can occur spontaneously or genetically, this review focuses on those forms of CJD and vCJD in which the disease risk has been acquired through one of a s...
Date:   Oct 2010
Title:   Pituitary hormones initiatives
Publisher:   Australian Government Department of Health and Ageing
Description:   This page contains information on the relation between human pituitary hormone treatment and Creutzfeldt-Jakob disease (CJD) as well as Government's initiatives for the control and prevention of CJD.
Date:   Oct 2010
Title:   Transmissible Spongiform Encephalopathies Advisory Committee (TSEAC)
Publisher:   National Health and Medical Research Council
Description:   TSEAC provides independent and timely expert advice on measures necessary to prevent and limit the spread of variant Creutzfeldt-Jakob Disease and other Transmissible Spongiform Encephalopathies (TSEs) in Australia.
Date:   Jul 2010
Title:   Australia's measures to protect human health
Publisher:   Australian Government Department of Health and Ageing
Description:   This page contains details of measures taken by the Australian Government to protect the health of the Australian public from bovine spongiform encephalopathy (BSE) and variant Creutzfeldt-Jakob disease (vCJD).
Date:   Feb 2010
Title:   Creutzfeldt-Jakob disease
Publisher:   Better Health Channel
Description:   Creutzfeldt-Jakob disease (CJD) is a rapidly progressive disease that causes deterioration of the brain and dementia. It is one of a group of rare diseases that affects humans and animals. Variant CJD is mistakenly referred to as 'mad cow disease'. There is no cure for CJD and death usually results within two years of the symptoms first appearing.
Date:   Jan 2010
Title:   Frequently asked questions
Publisher:   Australian Government Department of Health and Ageing
Description:   This page contains questions and answers about bovine spongiform encephalopathy (BSE) in animals and its links with variant Creutzfeldt-Jakob disease (vCJD) in humans.
Date:   Oct 2009
Title:   Bovine Spongiform Encephalopathy (BSE) in animals
Publisher:   Australian Government Department of Health and Ageing
Description:   Entry to the Department's web pages on bovine spongiform encephalopathy (BSE) in animals and its links to variant Creutzfeldt-Jakob disease (vCJD) in humans.
Date:   Oct 2009
Title:   Creutzfeldt-Jakob disease - myDr.com.au
Publisher:   myDr
Description:   Creutzfeldt-Jakob disease (CJD) is a degenerative brain disorder that causes rapidly progressive dementia. There are 2 main types of CJD - classical and variant.
Date:   Mar 2009
Title:   Mad cow disease (Creutzfeldt-Jacob disease, transmissible spongiform encephalopathy; new variant CJD)
Publisher:   Virtual Medical Centre.com
Description:   Information on the symptoms, treatment and diagnosis of Creutzfeldt Jakob disease syndrome or mad cow disease written by professional medical specialists.
Date:   Feb 2008
Title:   Transmissible Spongiform Encephalopathies (TSEs) questionnaire for sponsors
Publisher:   Australian Government Department of Health and Ageing
Description:   This questionnaire has been designed by the TGA in consultation with Australian industry bodies to facilitate the collection of data to enable Sponsors to self-certify their therapeutic goods against the TGA's 'Supplementary requirements for therapeutic goods for minimising the risk of transmitting transmissible spongiform encephalopathies (TSE)'
Date:   Dec 2004
Title:   Supplementary requirements for therapeutic goods for minimising the risk of transmitting Transmissible Spongiform Encephalopathies (TSEs)
Publisher:   Australian Government Department of Health and Ageing
Description:   Guidance on the management of TSE risks associated with putatively 'low-risk' ingredients
Date:   Dec 2004
Title:   TGA approach to minimising the risk of exposure to transmissible spongiform encephalopathies (TSEs) through medicines and medical devices
Publisher:   Australian Government Department of Health and Ageing
Description:   TSEs, caused by agents known as prions, include scrapie in sheep and goats, chronic wasting disease in deer, bovine spongiform encephalopathy (BSE) in cattle, and Kuru and Creutzfeldt-Jacob Disease (CJD) in humans
Date:   Dec 2004
Title:   Creutzfeldt-Jakob disease information
Publisher:   Australian Government Department of Health and Ageing
Description:   Creutzfeldt-Jakob disease (CJD) information and a link to printable version in PDF format
Date:   Sep 2004
Title:   Requirements for the assessment of medical devices containing animal material
Publisher:   Australian Government Department of Health and Ageing
Description:   Requirements for the assessment of medical devices containing animal material, with particular regard to the minimisation of risks relating to transmitting transmissible spongiform encephalopathies (TSEs)
Date:   Aug 2003

Results 1 to 16 displayed.